Literature DB >> 9613622

Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain.

F M Benes1.   

Abstract

In the past decade, there has been increased interest in whether discreet alterations of neural circuitry might play a role in the pathophysiology of schizophrenia. In the absence of a readily identifiable histopathology, a variety of sophisticated neurobiological approaches is being applied to the study of this disorder. In one series of investigations, subtle abnormalities have been detected in the anterior cingulate cortex-layer II (ACCx-II) of schizophrenia patients. One of these studies suggested a reduction of nonpyramidal neurons in schizophrenia patients, and it was postulated that this change could give rise to a relative increase of dopaminergic inputs to the remaining gamma-aminobutyric acid (GABA) cells. Although empiric evidence in support of this hypothesis was obtained, a subsequent post hoc analysis, described in this report, has suggested that this change could have occurred irrespective of whether GABA cells are reduced in number. A shift of cortical dopamine afferents from pyramidal to nonpyramidal neurons in ACCx-II seems to provide a more plausible explanation for such a "miswiring." These findings support critical use of model generation and testing as powerful tools for unraveling the nature of altered neural circuitry in postmortem schizophrenic brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613622     DOI: 10.1093/oxfordjournals.schbul.a033322

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  20 in total

Review 1.  Hippocampal neurons in schizophrenia.

Authors:  S Heckers; C Konradi
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

Review 2.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

3.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

4.  Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.

Authors:  P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  Schizophr Bull       Date:  2009-08-07       Impact factor: 9.306

5.  Additivities of compounds that increase the numbers of high affinity [3H]muscimol binding sites by different amounts define more than 9 GABA(A) receptor complexes in rat forebrain: implications for schizophrenia and clozapine research.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  2000-12       Impact factor: 3.996

6.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia.

Authors:  Robert C Welsh; Ashley C Chen; Stephan F Taylor
Journal:  Schizophr Bull       Date:  2008-11-05       Impact factor: 9.306

7.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

Review 8.  Are anticorrelated networks in the brain relevant to schizophrenia?

Authors:  Peter Williamson
Journal:  Schizophr Bull       Date:  2007-05-10       Impact factor: 9.306

9.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

Review 10.  Modulating neural plasticity with non-invasive brain stimulation in schizophrenia.

Authors:  Alkomiet Hasan; Thomas Wobrock; Tarek Rajji; Berend Malchow; Zafiris J Daskalakis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-24       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.